Traditional wound care and advanced wound care products are used to treat acute and chronic wounds. Chronic wounds take substantial time to heal and are expensive to treat. Advanced wound care has emerged as a standard solution for treating chronic wounds. Traditional wound care products are being substituted by advanced wound care products due to their efficacy and effectiveness in managing wounds by enabling faster healing.

The world advanced wound care market was valued at $7,117 million in 2015 and is expected to reach $12,454 million, growing at a CAGR of 8.3% during 2016-2022. Market growth is attributed to the rapid increase in the incidence of chronic diseases such as diabetes, changing lifestyle factors, and attempts to reduce the duration of hospital stays to limit the surgical costs. In addition, the demand for advanced wound care market is driven by favorable reimbursement scenario, increasing healthcare expenditure by the government, and rising inclination towards products that enhance therapeutic outcomes. However, high cost of advanced wound care products coupled with low awareness, especially in underdeveloped countries such as Nigeria, Afghanistan, and Bhutan, are expected to restrain the market growth.

The world advanced wound care market is segmented on the basis of product type, application, end user, and geography. By product type, it is segmented into infection management, exudate management, active wound care, and therapy devices. Infection management is the leading segment, which is further divided into silver dressings, non-silver dressings, and collagens. Based on application, it is bifurcated into chronic wound care and acute wound care. On the basis of end user, it is divided into hospitals and community centers. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 10.4%, owing to growing demand for advanced wound care products, rising geriatric population, and increasing unmet medical needs.

Companies included in this report are:

3M Company

Smith & Nephew plc

Coloplast A/S

Medtronic plc

Acelity L.P. Inc.

ConvaTec Healthcare B S.à.r.l.

Mölnlycke Health Care AB (a subsidiary of INVESTOR AB)

BSN Medical GmbH

Alliqua BioMedical, Inc.

Integra LifeSciences Holdings Corporation

KEY BENEFITS FOR STAKEHOLDERS:

The report provides an in-depth analysis of the advanced wound care market across major geographies and total revenue generated during the forecast period.

Quantitative analysis of the current trends and future estimations from 2015 to 2022 is presented, which assists the manufacturers to analyze the market.

The projections in the report are made by analyzing the current market trends and highlighting the market potential, in terms of value.

Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

The report also provides quantitative as well as qualitative market trends to facilitate the stakeholders in understanding the situations prevailing in the market.

SWOT analysis studies the internal environment of the leading companies for strategy formulation.

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...